Soares and colleagues demonstrated that NLRP1 gain-of-function variants protect against diabetic kidney disease in humans, highlighting an emerging protective role of NLRP1 against metabolic stress (72). This evidence concerns the gene NLRP1 and diabetic kidney disease.